{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:50:23Z","timestamp":1761663023645},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,10,30]],"date-time":"2011-10-30T00:00:00Z","timestamp":1319932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00705-011-1149-y","type":"journal-article","created":{"date-parts":[[2011,10,29]],"date-time":"2011-10-29T04:19:31Z","timestamp":1319861971000},"page":"329-332","source":"Crossref","is-referenced-by-count":14,"title":["Risk factors associated with hepatitis C virus infection in an urban population of the State of Mexico"],"prefix":"10.1007","volume":"157","author":[{"given":"S.","family":"Romero-Figueroa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ceballos-Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Santill\u00e1n-Arreygue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Miranda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rubio-Lezama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J.","family":"Gardu\u00f1o-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,30]]},"reference":[{"key":"1149_CR1","unstructured":"World Health Organization (2011) Viral hepatitis 12 november 2009: report by the secretariat: http:\/\/apps.who.int\/gb\/ebwha\/pdffiles\/EB126\/\/B12615-en.pdf\/EB\/126715 . Accessed 20 August 2011"},{"issue":"3","key":"1149_CR2","first-page":"227","volume":"44","author":"A Ben\u00edtez","year":"2006","unstructured":"Ben\u00edtez A, Cortez G, Novelo G et al (2006) Prevalencia del virus de hepatitis C en el banco de sangre del Centro Medico Nacional de La Raza. Rev Med Inst Mex Seguro Soc 44(3):227\u2013233","journal-title":"Rev Med Inst Mex Seguro Soc"},{"issue":"18","key":"1149_CR3","first-page":"1","volume":"7","author":"JF Sosa","year":"2010","unstructured":"Sosa JF, Santos LG, Guzm\u00e1n FB et al (2010) Hepatitis C virus infection in blood donors from the state of Puebla M\u00e9xico. Virol J 7(18):1\u20136","journal-title":"Virol J"},{"issue":"4","key":"1149_CR4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10620-005-2565-1","volume":"50","author":"N M\u00e9ndez-S\u00e1nchez","year":"2005","unstructured":"M\u00e9ndez-S\u00e1nchez N, Ponciano-Rodriguez G, Ch\u00e1vez-Tapia NC, Motola-Kuba D, Almeda-Valdes P, S\u00e1nchez-Lara K, Ramos MH, Uribe M (2005) Prevalence of hepatitis C infection in a population of asymptomatic people in a checkup unit in Mexico city. Dig Dis Sci 50(4):733\u2013737","journal-title":"Dig Dis Sci"},{"key":"1149_CR5","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/j.1537-2995.2009.02248.x","volume":"49","author":"GM Calder\u00f3n","year":"2009","unstructured":"Calder\u00f3n GM, Gonz\u00e1lez VF, Gonz\u00e1lez BC et al (2009) Transfusion 49:2200\u20132207","journal-title":"Transfusion"},{"issue":"10","key":"1149_CR6","first-page":"1240","volume":"127","author":"MR Armas","year":"1999","unstructured":"Armas MR, Wolff C, Soto R et al (1999) Hepatitis C virus and disease that it produces. Rev Med Chile 127(10):1240\u20131254","journal-title":"Rev Med Chile"},{"key":"1149_CR7","volume-title":"Hepatitis: causes, treatments and resources s.l.","author":"E Moore","year":"2006","unstructured":"Moore E (2006) Hepatitis: causes, treatments and resources s.l. McFarland and Company, Jefferson"},{"issue":"6","key":"1149_CR8","first-page":"657","volume":"140","author":"MR L\u00f3pez","year":"2004","unstructured":"L\u00f3pez MR, Zavala MC, Arenas EA (2004) Prevalence for seropositivity for HIV, hepatitis B and hepatitis C in blood donors. Gac Med Mex 140(6):657\u2013660","journal-title":"Gac Med Mex"},{"issue":"7","key":"1149_CR9","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jama.297.7.724","volume":"297","author":"JD Scott","year":"2007","unstructured":"Scott JD, Gretch D (2007) Molecular diagnostics of hepatitis C virus infection. JAMA 297(7):724\u2013732","journal-title":"JAMA"},{"issue":"RR-3","key":"1149_CR10","first-page":"1","volume":"52","author":"MJ Alter","year":"2003","unstructured":"Alter MJ, Kuhnert WL, Finelli L (2003) Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for disease control and prevention. MMWR Recomm Rep 52(RR-3):1\u201313","journal-title":"MMWR Recomm Rep"},{"key":"1149_CR11","unstructured":"Z\u00e1rate F, Cervantes R, Mata N et al (2008) Actualizaci\u00f3n en el diagn\u00f3stico y tratamiento de la hepatitis B y C. Revista de Enfermedades Infecciosas en Pediatr\u00eda 21\u201323"},{"issue":"9","key":"1149_CR12","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1128\/JCM.42.9.4321-4322.2004","volume":"42","author":"N M\u00e9ndez-S\u00e1nchez","year":"2004","unstructured":"M\u00e9ndez-S\u00e1nchez N, Motola-Kuba D, Chavez-Tapia NC, Bahena J, Correa-Rotter R, Uribe M (2004) Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico. J Clin Microbiol 42(9):4321\u20134322","journal-title":"J Clin Microbiol"},{"issue":"49","key":"1149_CR13","first-page":"5325","volume":"3","author":"J Valdespino","year":"2007","unstructured":"Valdespino J, Conde GC, Olaiz FG et al (2007) Seroprevalerencia de la Hepatitis C en adultos de M\u00e9xico: \u00bfun problema de salud publica emergente? Salud P\u00fablica de M\u00e9xico 3(49):5325\u20135403","journal-title":"Salud P\u00fablica de M\u00e9xico"},{"key":"1149_CR14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.arcmed.2007.03.001","volume":"38","author":"VM Dehesa","year":"2007","unstructured":"Dehesa VM, Nu\u00f1ez NR (2007) Epidemiology of hepatitis virus B and C. Arch Med Res 38:606\u2013611","journal-title":"Arch Med Res"},{"issue":"Suppl","key":"1149_CR15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1665-2681(19)31719-3","volume":"9","author":"N M\u00e9ndez-S\u00e1nchez","year":"2010","unstructured":"M\u00e9ndez-S\u00e1nchez N, Guti\u00e9rrez-Grobe Y, Kobashi-Marg\u00e1in RA (2010) Epidemiology of HCV infection in Latin America. Ann Hepatol 9(Suppl):27\u201329","journal-title":"Ann Hepatol"},{"issue":"110","key":"1149_CR16","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/oxfordjournals.aje.a116023","volume":"134","author":"JG Donahue","year":"1991","unstructured":"Donahue JG, Kenrad NE, Mu\u00f1oz A et al (1991) Antibody to Hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drugs users in Baltimore Maryland. Am J Epidemol 134(110):1206\u20131211","journal-title":"Am J Epidemol"},{"key":"1149_CR17","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1053\/jhep.2001.29303","volume":"34","author":"M Briggs","year":"2001","unstructured":"Briggs M, Baker C, Hall R et al (2001) Prevalence and risk factors for Hepatitis C virus infection at an urban veterans administration medical center. Hepatology 34:1200\u20131205","journal-title":"Hepatology"},{"issue":"1","key":"1149_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000096306","volume":"50","author":"E Chiquete","year":"2007","unstructured":"Chiquete E, Panduro A (2007) Low prevalence of anti-hepatitis C virus antibodies in Mexico: a systematic review. Intervirology 50(1):1\u20138","journal-title":"Intervirology"},{"key":"1149_CR19","doi-asserted-by":"crossref","unstructured":"Dehesa-Violante M, Nu\u00f1ez-Nateras R (2007) Epidemiology of hepatitis virus B and C. Arch Med Res 38:606\u2013611","DOI":"10.1016\/j.arcmed.2007.03.001"},{"key":"1149_CR20","unstructured":"Norma Oficial Mexicana NOM-017-SSA2 para la vigilancia Epidemiol\u00f3gica. Diario Oficial de la Federaci\u00f3n 17 de Noviembre de 1994"},{"key":"1149_CR21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.arcmed.2005.11.010","volume":"37","author":"CF Garc\u00eda","year":"2006","unstructured":"Garc\u00eda CF, Nev\u00e1rez SA, Constantino CP et al (2006) Cost-effectiveness of chronic hepatitis C treatment with thymosin alpha-1 at the Mexican institute of social security. Arch Med Res 37:663\u2013673","journal-title":"Arch Med Res"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-011-1149-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-011-1149-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-011-1149-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T18:22:23Z","timestamp":1593195743000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-011-1149-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,30]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["1149"],"URL":"https:\/\/doi.org\/10.1007\/s00705-011-1149-y","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"type":"print","value":"0304-8608"},{"type":"electronic","value":"1432-8798"}],"subject":[],"published":{"date-parts":[[2011,10,30]]}}}